Literature DB >> 17339431

Cutting Edge: Proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes.

Sofia I Bogiatzi1, Isabel Fernandez, Jean-Christophe Bichet, Marie-Annick Marloie-Provost, Elisabetta Volpe, Xavier Sastre, Vassili Soumelis.   

Abstract

Thymic stromal lymphopoietin (TSLP) is an epithelial cell-derived cytokine that strongly activates dendritic cells (DC) and can initiate allergic inflammation. The factors inducing the production of human TSLP are not known. In this study, we show that proinflammatory (TNF-alpha or IL-1alpha) and Th2 (IL-4 or IL-13) cytokines synergized to induce the production of TSLP in human skin explants. TSLP production in situ was restricted to epidermal keratinocytes of the suprabasal layer. TSLP production could not be inhibited by factors regulating Th2 inflammation, such as IL-10, TGF-beta, or IFN-gamma. Cytokine-treated skin culture supernatants induced the maturation of blood CD11c(+) DC in a TSLP-dependent manner. Our data provide the first evidence of TSLP induction and subsequent DC activation in human skin. Blocking TSLP-inducing cytokines could represent a novel strategy for the treatment of allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17339431     DOI: 10.4049/jimmunol.178.6.3373

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  89 in total

Review 1.  Epidermal TSLP: a trigger factor for pathogenesis of atopic dermatitis.

Authors:  Arup K Indra
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

Review 2.  Functions of thymic stromal lymphopoietin in immunity and disease.

Authors:  Yanlu Zhang; Baohua Zhou
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

3.  Dibutyl phthalate-induced thymic stromal lymphopoietin is required for Th2 contact hypersensitivity responses.

Authors:  Ryan P Larson; Simone C Zimmerli; Michael R Comeau; Andrea Itano; Miyuki Omori; Masanori Iseki; Conrad Hauser; Steven F Ziegler
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

4.  Thymic stromal lymphopoietin expression in allergic pulmonary inflammation is Pin1-dependent.

Authors:  Stephane Esnault; Louis A Rosenthal; Zhong-Jian Shen; Cara J Westmark; Ronald L Sorkness; James S Malter
Journal:  J Allergy Clin Immunol       Date:  2008-04-18       Impact factor: 10.793

5.  Lipopolysaccharide-Activated Leukocytes Enhance Thymic Stromal Lymphopoietin Production in a Mouse Air-Pouch-Type Inflammation Model.

Authors:  Ryosuke Segawa; Natsumi Mizuno; Takahiro Hatayama; Dong Jiangxu; Masahiro Hiratsuka; Yasuo Endo; Noriyasu Hirasawa
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

6.  Triclosan Induces Thymic Stromal Lymphopoietin in Skin Promoting Th2 Allergic Responses.

Authors:  Nikki B Marshall; Ewa Lukomska; Carrie M Long; Michael L Kashon; Douglas D Sharpnack; Ajay P Nayak; Katie L Anderson; B Jean Meade; Stacey E Anderson
Journal:  Toxicol Sci       Date:  2015-06-05       Impact factor: 4.849

Review 7.  Epidermal Lipids: Key Mediators of Atopic Dermatitis Pathogenesis.

Authors:  Nilika Bhattacharya; William J Sato; Avalon Kelly; Gitali Ganguli-Indra; Arup K Indra
Journal:  Trends Mol Med       Date:  2019-05-01       Impact factor: 11.951

8.  Chrysophanol, an anthraquinone from AST2017-01, possesses the anti-proliferative effect through increasing p53 protein levels in human mast cells.

Authors:  Na-Ra Han; Hee-Yun Kim; Soonsik Kang; Mi Hye Kim; Kyoung Wan Yoon; Phil-Dong Moon; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  Inflamm Res       Date:  2019-05-04       Impact factor: 4.575

Review 9.  Thymic stromal lymphopoietin: a new cytokine in asthma.

Authors:  Yrina Rochman; Warren J Leonard
Journal:  Curr Opin Pharmacol       Date:  2008-04-29       Impact factor: 5.547

10.  No evidence for TSLP pathway activity in human breast cancer.

Authors:  Cristina Ghirelli; Benjamin Sadacca; Fabien Reyal; Raphaël Zollinger; Paula Michea; Philémon Sirven; Lucia Pattarini; Carolina Martínez-Cingolani; Maude Guillot-Delost; André Nicolas; Alix Scholer-Dahirel; Vassili Soumelis
Journal:  Oncoimmunology       Date:  2016-05-09       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.